Manulife (Manufacturers Life Insurance)
ODT

Manulife (Manufacturers Life Insurance)’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,565
Closed -$203K – 3168
2020
Q4 		$203K Buy
+10,565
New +$163K ﹤0.01% 2766
2020
Q3 		– Sell
-8,341
Closed -$356K – 2952
2020
Q2 		$356K Buy
8,341
+473
+6% +$15.3K ﹤0.01% 2136
2020
Q1 		$217K Buy
7,868
+199
+3% +$5.8K ﹤0.01% 2278
2019
Q4 		$249K Buy
+7,669
New +$238K ﹤0.01% 2451
2019
Q3 		– Sell
-5,848
Closed -$215K – 2942
2019
Q2 		$215K Buy
+5,848
New +$140K ﹤0.01% 2599
2018
Q3 		– Sell
-774
Closed -$17K – 4074
2018
Q2 		$17K Sell
774
-5,264
-87% -$123K ﹤0.01% 3793
2018
Q1 		$128K Buy
+6,038
New +$142K ﹤0.01% 3329

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ODT Position: Q1 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 10,565 shares — an estimated $203K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ODT in Q1 2018 and held it in 7 quarters. The position peaked at $356K in Q2 2020. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 10,565 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $203K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s Odonate Therapeutics, Inc. Common Stock position peaked at $356K in Q2 2020.
  • 83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2021, filed 3 May 2021.